Resveratrol, an HDAC inhibitor, modulate epigenetic methylation negatively and acetylation positively by restoring expression of BRCA1, p53 and p21 genes in breast cancer cell lines (26, 27). The gene discussed is BRCA1; the disease is breast carcinoma.